'They are trying to hide...': Medical experts weigh in on Trump's 'bruised' hand; press sec dismisses speculations
A recent close-up of Donald Trump's hand at a press event has sparked fresh speculation about the Republican leader's 'bruised' hand.
Viewers noticed what looked like heavy makeup covering a patch on the back of his hand, raising concerns about the US president's health.
Trump was speaking at the White House on Tuesday during a joint appearance with French President Emmanuel Macron.
The MAGA chief addressed a range of hot-button issues, including questions around the Jeffrey Epstein files. However, viewers turned their attention to something else: his hand.
A noticeable area on Trump's hand seemed to be covered in tan liquid foundation, raising eyebrows as to whether it was meant to conceal bruising or some other mark.
The photo quickly spread online, adding to earlier concerns after similar marks were spotted in spring 2024.
This appearance has reignited debate, with some observers jokingly attributing it to Trump's famously strong handshake with Macron, while others worry it could signal age-related health issues.
In response to the hot topic, White House press secretary Karoline Leavitt defended the president's condition.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
A failing liver is taking my son away from me. Help him!
Donate For Health
Donate Now
Undo
'President Trump is a man of the people. His commitment is unwavering, and he proves that every single day,' she said. In a further statement, she added: 'President Trump has bruises on his hand because he's constantly working and shaking hands all day every day,' according to reports in the Irish Star.
Here's what the medical experts say:
'Shaking too many hands is a stretch'
Medical professionals have since weighed in with their expert opinions. Doctor Neal Patel, a primary care doctor based in California, reviewed the footage and expressed scepticism.
'Shaking too many hands is a little bit a stretch. President Trump has had something like this in the past, and from my experience and my patients, I would put that lower on the list of possibilities.'
Patel noted that bruising from a simple blood draw would be considered entirely normal for someone in their late 70s and is commonly seen in older adults.
'Trying to hide it'
Offering another perspective, New York-based urologist and men's health expert doctor Boback Berookhim told the Daily Mail: 'More likely than not, he has some bruising on his hand and they are trying to hide it.
It could be from a blood draw, an insect bite or potentially from hitting his hand against something.'
'It could be a simple routine physical. Perhaps he is on medications that need monitoring; maybe he was having some complaint and they wanted to look further,' Berookhim added.
Trump recently underwent a comprehensive physical exam at Walter Reed National Military Medical Center in April. Conducted by doctor Sean Barbabella, the evaluation lasted nearly five hours and included cognitive testing. Trump later said he 'did well' in the assessment.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
13 minutes ago
- Business Standard
Eris Lifesciences to tap Rs 5,000-cr insulin and semaglutide market in FY26
Ahmedabad-based Eris Lifesciences is looking to tap opportunities in the nearly Rs 5,000-crore Indian insulin market after Danish drugmaker Novo Nordisk announced the withdrawal of its insulin products from the market in April this year. 'We expect that Novo's cartridge inventory in the market will run out by October 2025. So this market opportunity is something that one can start monetising from the November–December time frame,' the company's executive director and chief executive officer (CEO), Krishnakumar Vaidyanathan, told Business Standard. He added that the timing fits Eris' plans, as the cartridge filling capability of its Bhopal unit will start becoming operational from January. Vial manufacturing has already been commissioned at the unit, with the company creating a strategic stock of insulins. This comes at a time when Eris is already the largest domestic player in insulins. The company had acquired the India formulations business of Biocon Biologics last year — including established insulin brands Basalog and Insugen. 'Before the Biocon deal, we had a couple of homegrown insulin brands in the market, which did a combined Rs 60 crore in revenue last year. Basalog and Insugen had combined revenues of Rs 200 crore at the time of acquisition,' he said. He added that, with this, the company's insulin franchise has become significantly larger, with a 10 per cent market share. Eris is also among the prominent drugmakers looking to roll out generic versions of the blockbuster molecule semaglutide once its patent expires around March next year. Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist used as an active pharmaceutical ingredient in medications for obesity management and Type-II diabetes. According to Eris' investor presentation for the June quarter of 2025–26 (Q1FY26), the company is on track to be among the first launches in India in March 2026. The company has initiated validation of synthetic semaglutide cartridges at its European Union (EU)-approved AMD injectables site. 'We are also planning the validation of the recombinant semaglutide in our Bhopal plant later this year,' he added. As far as the go-to-market strategy is concerned, the company said it is already in a strong position because of its dominant presence in insulins and prior presence in the GLP market with the launch of liraglutide in September last year. For Q1FY26, Eris Lifesciences recorded a 40 per cent year-on-year (Y-o-Y) rise in consolidated profit after tax (PAT) to Rs 125 crore. Revenue rose to Rs 773 crore during the June quarter against Rs 720 crore in the year-ago period.
Time of India
36 minutes ago
- Time of India
5 early warning signs of leaky gut syndrome that one should not ignore
Human bodies are a complex system of nerves, tissues, and cells. What most of us don't realise is how intricately the system works. Each body part, nerve, and tissue is interconnected, and exclusively inside our bellies. We have an extensive intestinal lining covering more than 4,000 square feet of surface area. When our gut is working properly, it forms sort of a protective layer of tissues that controls what gets absorbed in the bloodstream, while if it is not working properly, an unhealthy gut may cause large holes in the gut lining that allows partially digested food and toxins to penetrate the tissues beneath it, triggering chronic inflammation and severe changes in gut's normal bacteria. Surprisingly, the research world is buzzing with studies showing that several modifications in intestinal bacteria and inflammation may play a major role in the development of several chronic issues and diseases, including leaky gut, which is a syndrome that is recognized as a 'presumed condition'. It is founded on the idea of relative intestinal permeability What is leaky gut Leaky gut, commonly defined as increased intestinal permeability, occurs when the lining of the small intestine is destroyed, allowing undigested food particles, toxins, and germs to 'leak": through the intestines and into the bloodstream. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like They were so beautiful before; look at them now; number 10 will Surprise you Undo Although this is a syndrome that is hypothetically recognized and is not currently well-studied as a medical diagnosis. It is severely based on the concept that increased permeability occurs in some gastrointestinal diseases. Intestinal permeability and leaky gut syndrome Intestinal permeability is the property that allows solute and fluid exchange between the lumen and tissues. Conversely, intestinal barrier function refers to the ability of the mucosa and extracellular barrier components, such as mucus, to prevent this exchange. A critical function of the intestinal epithelium is to form a barrier that prevents the permeation of pro-inflammatory molecules, such as pathogens, toxins, and antigens, from the luminal environment into the mucosal tissues and circulatory system. As stated by researchers in their study 'Intestinal Permeability Regulation by Tight Junction: Implication on Inflammatory Bowel Diseases,' conducted back in 2015. While its evidence suggests that it is related to the Irritable bowel syndrome (IBS), it contributes to several other diseases as well, such as Crohn's disease, diabetes, chronic liver disease, celiac disease, etc. Potential warning signs of leaky gut syndrome Most of the warning signs of the leaky gut syndrome mimic the symptoms of other health conditions and that is why, without a proper diagnosis, it is impossible to say someone has it. (source: Cleveland clinc) Its symptoms include: Diarrhea, constipation, and bloating These digestive issues might be an indication that something is going on with your digestive system, and your gut health is compromised. The damaged intestinal lining affects nutrient absorption and causes digestive discomfort. Unhealthy diet Diets high in refined sugars, gluten, processed foods, and artificial additives can irritate the gut lining. In addition, nutritional deficiencies in zinc, vitamin A, and vitamin D can also weaken the intestinal barrier. Chronic inflammation Inflammation is responsible for a lot of things that happen in our bodies. Conditions like inflammatory bowel disease (IBD), Crohn's disease, and ulcerative colitis are caused by inflammation that can also contribute to intestinal permeability. Acne, Psoriasis, and other skin conditions Acne and other skin conditions are the immune system's reaction to the toxins present in our bodies. It is not difficult to conclude that these toxins can be the byproduct of leaky gut. Food sensitivities Some of the most common offenders are gluten, dairy, and certain food grains. These can trigger an inflammatory reaction in sensitive people, usually manifesting itself as bloating, fatigue and inflammation.
Time of India
an hour ago
- Time of India
Why are experts warning against Benadryl, the common cough syrup?
Benadryl, a medicine many households have relied on for decades, is now under serious scrutiny from health experts. Known for treating allergies, cough, cold, and even used as a sleep aid, Benadryl (which contains the drug diphenhydramine) is being called outdated and potentially risky. A new review published in February 2025 by allergy experts from Johns Hopkins University and the University of California, San Diego, is urging for the drug to be pulled from over-the-counter (OTC) and prescription markets in the U.S. due to its side effects and availability of safer alternatives. Here's why medical professionals are now advising people to think twice before reaching for this common medication. Outdated and risky, say experts Diphenhydramine was approved back in 1946 as a first-generation antihistamine. While it does help manage allergy symptoms like sneezing and itching, experts argue it affects more than just the allergy-related parts of the brain. It can also cause sedation, dizziness, confusion, and even dangerous heart issues. According to the review, Benadryl poses more harm than newer antihistamines, especially for young children and older adults. The drug can stay in the body for up to 18 hours in seniors, leading to ongoing drowsiness and increased risk of falls. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like No annual fees for life UnionBank Credit Card Apply Now Undo In children, misuse can cause agitation, extreme sedation, or even coma and death in rare cases. Not the best choice for allergic reactions Despite its popularity, some doctors say Benadryl isn't the best option during severe allergic reactions. Dr. Anna Wolfson, an allergist at Massachusetts General Hospital, told CNN, 'If someone has an allergic reaction to a food, people will say, 'Don't worry, I have diphenhydramine in my purse,' and I would say, 'Really, epinephrine is the first-line treatment for food allergies.'' Benadryl affects acetylcholine, a brain chemical involved in memory and learning. A 2015 study in JAMA Internal Medicine found that those who used drugs that block acetylcholine, like Benadryl, had a 54% higher risk of dementia and a 63% greater chance of developing Alzheimer's. The World Allergy Organization Journal also linked diphenhydramine to poor academic outcomes, citing major declines in attention, memory, and processing speed. Not safe for children Doctors are also raising concerns about how diphenhydramine is being used in children. Dr. Alyssa Kuban, a pediatrician and associate medical director at Texas Children's Pediatrics, told CNN: 'I see some families use diphenhydramine when the child has a cold or upper respiratory infection, thinking it will help with the congestion and help them to sleep better at night. This is not effective for cold symptoms, nor is it very safe. ' Source: Getty Images Experts say that loratadine and cetirizine are safer for children over 6 months, while saline drops and suction are better for infants. Experts also pointed to social media risks. The drug was involved in dangerous viral trends like the "Benadryl Challenge," which led to child hospitalizations and even fatalities. What should you do? Although Benadryl is found in over 300 products and still widely used, experts are clear: safer alternatives exist. Second-generation antihistamines like cetirizine and loratadine offer similar relief with fewer side effects and longer-lasting results. These newer medications don't cause the same level of sedation or cognitive impairment. The authors of the February 2024 review concluded: 'In the past, it has been a useful medication that has helped millions of patients; however, its current therapeutic ratio is matched or exceeded by second-generation antihistamines, especially due to their markedly reduced adverse reactions. It is time to say a final goodbye to diphenhydramine, a public health hazard.'
